company background image
1763 logo

China Isotope & Radiation SEHK:1763 Stock Report

Last Price

HK$10.34

Market Cap

HK$3.3b

7D

2.6%

1Y

-26.0%

Updated

16 Jul, 2024

Data

Company Financials

China Isotope & Radiation Corporation

SEHK:1763 Stock Report

Market Cap: HK$3.3b

1763 Stock Overview

Engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China.

1763 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health4/6
Dividends1/6

China Isotope & Radiation Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China Isotope & Radiation
Historical stock prices
Current Share PriceHK$10.34
52 Week HighHK$15.44
52 Week LowHK$9.03
Beta0.70
11 Month Change-0.96%
3 Month Change9.53%
1 Year Change-26.04%
33 Year Change-65.13%
5 Year Change-44.11%
Change since IPO-48.56%

Recent News & Updates

China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think

May 05
China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think

Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price

Apr 26
Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price

Recent updates

China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think

May 05
China Isotope & Radiation's (HKG:1763) Anemic Earnings Might Be Worse Than You Think

Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price

Apr 26
Why We're Not Concerned About China Isotope & Radiation Corporation's (HKG:1763) Share Price

China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet

Mar 28
China Isotope & Radiation (HKG:1763) Has A Rock Solid Balance Sheet

There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital

May 13
There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital

Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?

Feb 07
Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?

China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends

Dec 20
China Isotope & Radiation (HKG:1763) Will Want To Turn Around Its Return Trends

A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)

Oct 28
A Look At The Intrinsic Value Of China Isotope & Radiation Corporation (HKG:1763)

China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly

Sep 30
China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly

There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital

Aug 30
There Are Reasons To Feel Uneasy About China Isotope & Radiation's (HKG:1763) Returns On Capital

Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?

Jun 10
Is There Now An Opportunity In China Isotope & Radiation Corporation (HKG:1763)?

China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt

Apr 11
China Isotope & Radiation (HKG:1763) Could Easily Take On More Debt

Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?

Dec 28
Is It Time To Consider Buying China Isotope & Radiation Corporation (HKG:1763)?

China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly

Oct 26
China Isotope & Radiation (HKG:1763) Seems To Use Debt Quite Sensibly

Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal

Oct 08
Capital Allocation Trends At China Isotope & Radiation (HKG:1763) Aren't Ideal

Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?

Sep 05
Is Now An Opportune Moment To Examine China Isotope & Radiation Corporation (HKG:1763)?

Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture

Jun 13
Returns On Capital At China Isotope & Radiation (HKG:1763) Paint A Concerning Picture

When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?

May 24
When Should You Buy China Isotope & Radiation Corporation (HKG:1763)?

China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet

Apr 01
China Isotope & Radiation (HKG:1763) Has A Pretty Healthy Balance Sheet

Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)

Mar 14
Our Take On The Returns On Capital At China Isotope & Radiation (HKG:1763)

The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More

Feb 04
The China Isotope & Radiation (HKG:1763) Share Price Has Gained 24% And Shareholders Are Hoping For More

Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?

Jan 09
Is Now The Time To Look At Buying China Isotope & Radiation Corporation (HKG:1763)?

Will China Isotope & Radiation (HKG:1763) Multiply In Value Going Forward?

Dec 14
Will China Isotope & Radiation (HKG:1763) Multiply In Value Going Forward?

China Isotope & Radiation Corporation's (HKG:1763) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Nov 23
China Isotope & Radiation Corporation's (HKG:1763) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Shareholder Returns

1763HK Medical EquipmentHK Market
7D2.6%1.5%-0.2%
1Y-26.0%-48.3%1.5%

Return vs Industry: 1763 exceeded the Hong Kong Medical Equipment industry which returned -48.6% over the past year.

Return vs Market: 1763 underperformed the Hong Kong Market which returned 0.9% over the past year.

Price Volatility

Is 1763's price volatile compared to industry and market?
1763 volatility
1763 Average Weekly Movement5.5%
Medical Equipment Industry Average Movement6.9%
Market Average Movement6.8%
10% most volatile stocks in HK Market14.5%
10% least volatile stocks in HK Market3.6%

Stable Share Price: 1763 has not had significant price volatility in the past 3 months.

Volatility Over Time: 1763's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19833,105n/awww.circ.com.cn

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of diagnostic and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmaceuticals; urea breath test kits and analyzers; and in vitro immunoassay diagnostic reagents and kits.

China Isotope & Radiation Corporation Fundamentals Summary

How do China Isotope & Radiation's earnings and revenue compare to its market cap?
1763 fundamental statistics
Market capHK$3.31b
Earnings (TTM)HK$398.43m
Revenue (TTM)HK$7.13b

8.3x

P/E Ratio

0.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1763 income statement (TTM)
RevenueCN¥6.63b
Cost of RevenueCN¥3.15b
Gross ProfitCN¥3.48b
Other ExpensesCN¥3.11b
EarningsCN¥370.97m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.16
Gross Margin52.48%
Net Profit Margin5.59%
Debt/Equity Ratio23.0%

How did 1763 perform over the long term?

See historical performance and comparison

Dividends

3.3%

Current Dividend Yield

27%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.